“The Phase 1 clinical trial is designed to evaluate the safety, reactogenicity, and immunogenicity of ARCT-2304 as a potential vaccine to protect against the highly pathogenic H5N1 avian influenza ...
As H5N1 bird flu continues to spread around the US, health officials recently found that 7 percent of dairy workers tested on ...
A majority of the U.S. cases have been in California (21), Washington (11) and Colorado (10). Last week, a CDC study revealed ...
Over the weekend, British Columbia (BC) health officials reported a presumptive positive H5 avian flu infection in a teenager ...
A year after an outbreak of H5N1 killed thousands of elephant seals, only about a third of the seals normally expected here ...
Health officials began providing the safety gear long before the first human case in California was announced in October.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback